Australia Pharmaceuticals & Biotech Healthy Companies

Biotron Limited, a biotechnology company, develops and commercializes novel small molecule antiviral therapeutics to treat various viral diseases in Australia.

AnteoTech Limited engages in developing, commercializing, manufacturing, and distributing products for the life sciences research, in-vitro diagnostics, energy, and medical device markets primarily in Australia.

Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia.

Neuren Pharmaceuticals Limited, a biopharmaceutical company, engages in the development of drugs for the treatment of chronic neurodevelopmental and neurodegenerative disorders, and acute traumatic brain injury.

PYC Therapeutics Limited provides drug discovery research and development services utilizing Phylomer peptide libraries and proprietary screening capabilities in Australia.

Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and related technologies for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia.

CannPal Animal Therapeutics Limited engages in the research and development of animal health products in Australia.

Exopharm Limited, a biopharmaceutical company, focuses on developing and commercializing human therapeutics in Australia.

IDT Australia Limited engages in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and finished drug products worldwide.

Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious and immune modulated diseases in Australia, the United States, and internationally.

Acrux Limited, together with its subsidiaries, develops and commercializes specialty and generic topical pharmaceuticals in Australia, Switzerland, Germany, the United States, and internationally.

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand.

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia.

Sienna Cancer Diagnostics Limited, a medical technology company, identifies, develops, and commercializes cancer-related in-vitro diagnostic tests for use in pathology laboratories worldwide.

Anatara Lifesciences Limited engages in the research and development of non-antibiotic oral solutions for gastro intestinal diseases in animals and humans in Australia.

AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, markets, and sells cannabinoids-based pharmaceuticals in Australia and internationally.